Meanwhile, it is important to recognize that disruptions in VEGF-A/VEGFR2 signaling in diabetes exhibit tissue-specific patterns, and VEGF-A resistance is not uniformly present across all vascular beds. The gene discussed is VEGFA; the disease is diabetes mellitus.